Drug intelligence / Profile preview

BDR-231

Development stage: Preclinical
Lead developer: MDimune
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies

Overview

BDR-231 is a preclinical **cell-derived vesicle** therapeutic program from **BioDrone Therapeutics** for **inflammatory diseases**. The candidate is described in the company's pipeline as an **MSC-derived cell-derived vesicle** product built on BioDrone's CDV platform, placing it within the extracellular vesicle and cell-therapy-adjacent space. Although no discrete molecular target, payload, route of administration, or indication-specific disease subtype has been publicly disclosed, the program appears intended to leverage the **immunomodulatory and regenerative signaling properties of mesenchymal stem cell-derived vesicles** to modulate inflammatory biology and potentially deliver therapeutic bioactive cargo in inflammatory conditions. The program is reported to be in **preclinical** development.

Other names: BioDrone Therapeutics CDV MSC-derived vesicle inflammatory program

Beyond the preview

Go deeper on BDR-231.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BDR-231.

Explore the full profile